May isn’t just a month of planting. It’s a season of rebellion. This cover story digs into the deep roots of cannabis activism, labor, and legacy. From May Day to World Bee Day, we explore the voices and movements that shaped cannabis culture long before legalization. Because rebellion isn’t a moment—it’s the soil this industry grew from.
Cannabis Industry’s $123 Billion Boost Is a Big F*ck You to Critics
The cannabis industry is expected to pump $123.6 billion into the U.S. economy in 2025. That’s not just growth—it’s a cultural reckoning. Built by the same community they tried to erase, this number doesn’t just shut down critics. It buries them.
Weed for Rich People: The Seth Rogen Effect
Seth Rogen has popularized cannabis culture, but his luxury brand Houseplant has shifted it toward exclusivity, prioritizing design over authenticity. While he contributes to cannabis advocacy, his efforts are seen as performative. The current cannabis landscape contrasts starkly with its rebellious origins, leading to concerns about gentrification and cultural appropriation in the industry.
Divine Hustle: Carmelo, Celebrity Weed, and the ‘Mission from God’ Marketing Myth
Carmelo Anthony says launching his new cannabis brand is a “mission from God.” But he’s not the first celebrity to use divine branding to sell premium weed. This feature dissects the language, the strategy, and the real message behind celebrity weed rollouts wrapped in purpose.
Build Fast, Die Loud: Why Big Weed Keeps Going Bust in California
Gold Flora’s implosion wasn’t a one-off—it was a warning. From ballooned budgets to influencer-backed ego trips, Big Weed’s collapse in California shows what happens when hype and hubris replace substance and sustainability. We break it all down and expose how the industry got too loud, too fast, and now can’t afford the silence.
The DEA’s Stance on Rescheduling: Progress or Stalemate?
The DEA is delaying the rescheduling of marijuana from Schedule I, despite overwhelming scientific support and recommendations from health authorities. This stalling harms the cannabis industry, patients, and communities affected by marijuana criminalization. Political influences from big pharmaceutical companies contribute to this resistance, prolonging the adverse effects of current drug policies.